Feedback / Questions
ELC-301 - Elicera Therap
https://www.elicera.com/press-releases/elicera-therapeutics-continues-the-phase-i-iia-carma-study-with-its-car-t-cell-therapy-as-planned-following-the-safety-committee-s-assessment-of-cohort-1
Apr 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next